BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 23026768)

  • 1. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
    Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and infections.
    Ling Y; Puel A
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():34-40. PubMed ID: 25398490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
    Puel A; Picard C; Cypowyj S; Lilic D; Abel L; Casanova JL
    Curr Opin Immunol; 2010 Aug; 22(4):467-74. PubMed ID: 20674321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.
    Okada S; Puel A; Casanova JL; Kobayashi M
    Clin Transl Immunology; 2016 Dec; 5(12):e114. PubMed ID: 28090315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
    Puel A; Cypowyj S; Bustamante J; Wright JF; Liu L; Lim HK; Migaud M; Israel L; Chrabieh M; Audry M; Gumbleton M; Toulon A; Bodemer C; El-Baghdadi J; Whitters M; Paradis T; Brooks J; Collins M; Wolfman NM; Al-Muhsen S; Galicchio M; Abel L; Picard C; Casanova JL
    Science; 2011 Apr; 332(6025):65-8. PubMed ID: 21350122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to infection in IL-17-deficient mice and humans.
    Cypowyj S; Picard C; Maródi L; Casanova JL; Puel A
    Eur J Immunol; 2012 Sep; 42(9):2246-54. PubMed ID: 22949323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
    Kisand K; Peterson P
    Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis.
    Ling Y; Cypowyj S; Aytekin C; Galicchio M; Camcioglu Y; Nepesov S; Ikinciogullari A; Dogu F; Belkadi A; Levy R; Migaud M; Boisson B; Bolze A; Itan Y; Goudin N; Cottineau J; Picard C; Abel L; Bustamante J; Casanova JL; Puel A
    J Exp Med; 2015 May; 212(5):619-31. PubMed ID: 25918342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CMCD: Chronic Mucocutaneous Candidiasis Disease].
    Okada S
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):109-117. PubMed ID: 28603201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
    Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
    Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
    Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
    J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.
    Ifrim DC; Quintin J; Meerstein-Kessel L; Plantinga TS; Joosten LA; van der Meer JW; van de Veerdonk FL; Netea MG
    Clin Exp Immunol; 2015 Sep; 181(3):434-40. PubMed ID: 25880788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
    Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
    J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.
    Soltész B; Tóth B; Sarkadi AK; Erdős M; Maródi L
    Int Rev Immunol; 2015; 34(4):348-63. PubMed ID: 26154078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies.
    Mogensen TH
    Front Immunol; 2018; 9():3047. PubMed ID: 30671054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.
    Huppler AR; Bishu S; Gaffen SL
    Arthritis Res Ther; 2012 Jul; 14(4):217. PubMed ID: 22838497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
    Hanna S; Etzioni A
    J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.
    Hong M; Ryan KR; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning DW; McConnell V; Cant AJ; Abinun M; Spickett GP; Swan DC; Gillespie CS; Young DA; Lilic D
    Clin Exp Immunol; 2009 Apr; 156(1):40-51. PubMed ID: 19196253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
    Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
    Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
    Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
    J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.